Mark Sheptoff Financial Planning, LLC Tg Therapeutics, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $177 Million
- Q1 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 300 shares of TGTX stock, worth $11,304. This represents 0.01% of its overall portfolio holdings.
Number of Shares
300Holding current value
$11,304% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
395Shares Held
89MCall Options Held
3.3MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA15.6MShares$588 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$429 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$124 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.68MShares$101 Million5.62% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.47B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...